Dr. Jennifer Leigh Clarke, MD, MPH

Dr. Clarke practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Clarke's NPI, 1972776623, was assigned on April 2, 2008. Dr. Clarke graduated from UCSF School of Medicine in 2002. Dr. Clarke holds California license A85636.

Dr. Clarke's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Clarke's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Clarke to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clarke practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Clarke's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Clarke is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Clarke's licenses on file in 2 states: California and New York.

CMS data shows 260 Medicare services from Dr. Clarke across 4 procedure codes in 2024, for 80 Medicare patients. Medicare paid $17,308 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Clarke in 2024. The largest group is 65 to 74, with 36 patients. 60% of them have high cholesterol, and 46% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Clarke's median patient age at 58, with 38% women.

In 2024, Dr. Clarke wrote 140 Medicare Part D claims for 34 patients. 74% of them were for generic drugs. CMS names the drug for 73 of them, across 4 drugs with 11 or more claims each, at $519,872 in total drug cost. In 2023, CMS named 61 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Clarke for performance year 2024, reported as part of a group. Dr. Clarke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Clarke as offering telehealth.

Dmand AI links 45 papers to Dr. Clarke, published from 2006 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Brain Neoplasms, Glioblastoma and Glioma. Dr. Clarke has published most often in J Neurooncol. Dr. Clarke's most frequent co-authors are Jennie Webster Taylor, MD, Nicholas A. Butowski, MD and Susan M. Chang, MD.

Dmand AI links Dr. Clarke to 5 clinical trials, 2 of them phase 2 studies. Conditions studied include Astrocytoma, Glioblastoma and Glioma. University of California, San Francisco sponsors the most, 4.

CMS Open Payments shows 20 general payments to Dr. Clarke from 3 drug and device companies from 2018 to 2024. Consulting fees make up the largest share, 76% of the total. Servier Pharmaceuticals LLC paid the most, $20,099. It also lists 22 research payments totaling $11,968 from 2023 to 2024.

Dmand AI lists 1 award for Dr. Clarke, most recently CMS Stage 1 EHR in 2013.

Dr. Clarke graduated from UCSF School of Medicine in 2002. Dr. Clarke is a member of ASCO.

Dr. Clarke is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.